Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Synthesis and Mechanistic Dissection of Biselyngbyaside Induced Cytotoxicity through Multi-omics Profiling

ABSTRACT: Deciphering the mechanism of action of natural products remains great challenges. Biselyngbyasides (BILs), a class of marine 18-membered macrolides, display strong cytotoxicity in various cancer cells, whereas, their molecular mechanisms remain poorly understood. Here, we establish a multi-omics strategy integrating chemotranscriptomics, phosphoproteomics and peptide-centric local stability assays (PELSA) to systematically characterize cellular responses triggered by biselyngbyolide A (BILA). Multi-omics data analysis demonstrates that BILA triggered a signaling cascade including ER stress, UPR activation, lipid metabolism remodeling, cell-cycle arrest, and apoptosis by inhibition of SERCA. Using synthetic BILA and its aza-analogue, we performed structure-function analysis and further pinpoint the core pharmacophore responsible for cytotoxicity. This study clarifies the full signaling network regulated by BILA and provides a versatile analytical tools for mechanistic investigation of complex natural products in early drug discovery.

ORGANISM(S): Homo sapiens

PROVIDER: GSE342138 | GEO | 2026/08/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy

Project description:CD19-directed chimeric antigen receptor (CAR) T-cell therapy has significantly advanced the treatment landscape for relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). However, up to 60% of patients do not achieve a complete response. In this study, we analyzed the infusion products of eight r/r DLBCL patients with distinct clinical responses to axicabtagene ciloleucel using single-cell transcriptomics. Compared to patients with progressive disease, infusion products of complete responders demonstrated stronger signatures of type I interferon (IFN-I) signaling and cytotoxicity. Based on these findings, we developed a novel strategy to improve CD19-directed CAR T-cell treatment efficacy by incorporating IFN-I during the ex vivo manufacturing process. While high-strength IFN-I signaling increases both CAR T-cell cytotoxicity and apoptosis, low-strength IFN-I signaling selectively enhances CAR T-cell cytotoxicity without compromising viability. Our manufacturing method leverages an existing FDA-approved pharmacophore to improve CAR T-cell efficacy without altering CAR expression or current manufacturing protocols. This study demonstrates proof-of-principle for IFN-I as a modulator to enhance CAR T-cell treatment efficacy in vivo, showcasing its translational potential for improving CAR T-cell therapy.

2026-04-16 | GSE283351 | GEO

Pathway-based network medicine identifies novel natural products for Alzheimer's disease

Project description:Natural products exhibit potential as candidates for developing multi-target agents for Alzheimer's disease treatment. The aim of this study is to utilize network-based medicine to identify novel natural products for Alzheimer's disease, and investigate their efficacy and mechanisms of action. In this study, we identified (-)-Vestitol and Salviolone as new potential natural products for treating Alzheimer's disease via an Alzheimer's disease-related pathway-gene network. Both natural products improved the cognition of APP/PS1 transgenic mice, reduced Aβ deposition, and lowered soluble toxic Aβ levels in the brain. Notably, a synergistic effect was observed when the two natural products were combined. Transcriptomic analysis and qRT-PCR experiments revealed that the synergistic mechanism of (-)-Vestitol and Salviolone combination is associated with the regulation of a broader range of AD-related pathways and genes, particularly the neuroactive ligand-receptor interaction pathway and calcium signaling pathway.

2025-02-19 | GSE270100 | GEO

Synthesis and Mechanistic Dissection of Biselyngbyaside Induced Cytotoxicity through Multi-omics Profiling

Project description:Synthesis and Mechanistic Dissection of Biselyngbyaside Induced Cytotoxicity through Multi-omics Profiling

| PRJNA1505656 | ENA

Project description:Nicotine-triggered multi-omics responses during denitrification by Paracoccus denitrificans ATCC 19367

| PRJNA1513437 | ENA

Project description:Natural products inhibiting neuroblastoma

| PRJNA1158969 | ENA

Gene regulatory programs of NK cells show that NCAM1 (CD56) and KIRs are controlled by genetically polymorphic distal regulatory elements [scATAC-seq]

Project description:Owing to their immunoprotective properties, natural killer (NK) cells are critical for the innate response to pathogens, as well as a new wave of cancer immunotherapy that harnesses natural cytotoxicity. We sought to understand the genetic and epigenetic drivers behind human specific NK cell receptors, so that we can better understand the underlying cellular function. Here, we present a transcriptomic, proteomic (CITE-seq), and chromatin (single nuclei ATAC-seq and Hi-C) analysis of human peripheral NK cell subsets, uncovering key regulatory programs governing NK cell differentiation. Through integrative multi-omics, we demonstrate that CD56bright versus CD56dim NK cell subsets have differential distal regulatory element (DRE) landscapes, with fewer accessible DREs in the CD56dim NK cells. We combine epigenetic, chromatin looping, and human genetic data to show mechanisms governing the NCAM1 (encoding CD56) and KIR loci. For example, we identify NCAM1 DREs that bind STAT in most NK cells, while identifying a genetic cohort that has motifs for binding repressive BLIMP1 at the DRE and resulting in less CD56 expression. Together, our findings reveal novel epigenetic and transcriptomic systems for regulation of NK cells cytotoxicity and diversity, deepening our understanding of their function and how transcription factor networks govern CD56bright versus CD56dim phenotypes.

2025-05-24 | GSE297712 | GEO

Gene regulatory programs of NK cells show that NCAM1 (CD56) and KIRs are controlled by genetically polymorphic distal regulatory elements [CITE-seq]

2025-05-27 | GSE298188 | GEO

Blood and urine multi-omics analysis of the impact of e-vaping, smoking and cessation – from exposome to molecular responses

Project description:Cigarette smoking is a major cause of preventable morbidity and mortality. While quitting smoking is the best option, switching from cigarettes to non-combustible alternatives (NCAs) such as e-vapor products is a viable harm reduction approach for smokers who would otherwise continue to smoke. A key challenge for the clinical assessment of NCAs is that self-reported product use can be unreliable, compromising the proper evaluation of their risk reduction potential. In this cross-sectional study with 205 healthy volunteers, we combined comprehensive exposure characterization with in-depth multi-omics profiling to compare effects across four study groups: cigarette smokers (CS), e-vapor users (EV), former smokers (FS) and never smokers (NS). Multi-omics analyses included metabolomics, transcriptomics, DNA methylomics, proteomics, and lipidomics. Comparison of the molecular effects between CS and NS recapitulated several previous observations, such as increases in inflammatory markers in CS. Generally, FS and EV demonstrated intermediate molecular effects between the NS and CS groups. Stratification of the FS and EV by combustion exposure markers suggested that this positioning on the scale between CS and NS was partially driven by non-compliance / dual use. Overall, this study highlights the importance of in-depth exposure characterization before biological effect characterization for any NCA assessment study.

2024-02-22 | E-MTAB-12751 | biostudies-arrayexpress

Discovery of novel macrolides: Epemicins A and B

Project description:Identification of two novel 30-membered glycosylated macrolides, epemicins A and B from the rare Kutzneria sp. CA-103260 with formulas C70H122N2O27 and C76H132N2O32. We also provide data on the successful heterologous expression of epemicin A in S. albus J1074 and on the abolishment of the production of the compounds via the generation of a knockout strain. The whole genome sequence of Kutzneria sp. CA-103260 available at: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=2802641&lvl=3&lin=f&keep=1&srchmode=1&unlock The published data are available at: https://pubs.acs.org/doi/full/10.1021/acschembio.1c00318

2021-07-20 | MSV000087858 | MassIVE

NKCLR3 impairs natural killer cell cytotoxicity by epigenetically targeting the Natural Cytotoxicity Triggering Receptor 1 (NCR1)

Project description:NKCLR3 impairs natural killer cell cytotoxicity by epigenetically targeting the Natural Cytotoxicity Triggering Receptor 1 (NCR1)

| PRJNA1200109 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data